• Y Boudjemai, P Mbida, V Potinet-Pagliaroli, F Géffard, G Leboucher, J-L Brazier, B Allenet, and B Charpiat.
• Faculty of Pharmacy, University of Montreal, C.P. 6128, succursale Centre-ville, Montréal (Québec) H3C 3J7, Canada.
• Ann Pharm Fr. 2013 Jul 1;71(4):260-7.

UnlabelledParacetamol is the most widely used analgesic and antipyretic drug. In France, little is known concerning patients' knowledge and beliefs about paracetamol.ObjectiveTo determine how much outpatients attending an emergency department know about paracetamol.MethodA semi-structured questionnaire was applied to patients consulting for non-severe medical or traumatic conditions.ResultsThirty-three (45%) of 73 participating patients knew that paracetamol was the active ingredient of the medication they used to reduce pain and/or fever. Three patients thought 2g was the maximum recommended single dose; 25% thought that a delay between two doses ≤ 3 hours was recommended and 15% thought the maximum daily dose was > 4 g. While 8% cited liver toxicity as a side effect, 38% did not believe an excessive dose could be fatal. Two patients correctly answered all questions and five gave no correct answer.DiscussionOutpatients attending an emergency department (ED) have poor knowledge about paracetamol. This situation is disturbing and our results may serve as an eye opener to healthcare professionals. They emphasize the need for research programs with the following objectives: a) to determine the actual content of the message delivered by healthcare professionals; b) to study conditions under which this message is issued; c) to analyze how patients understand key messages and what their behavioral response is.ConclusionIn ED patients, the level of knowledge about paracetamol is insufficient to ensure its safe use in ambulatory care. Further studies are needed to determine the causes and to permit better patient education.Copyright © 2013 Elsevier Masson SAS. All rights reserved.

34 keywords...

hide…